Efficacy, Compliance and Reasons for Refusal of Postoperative Chemotherapy for Elderly Patients with Colorectal Cancer: A Retrospective Chart Review and Telephone Patient Questionnaire
Open Access
- 22 February 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (2), e55494
- https://doi.org/10.1371/journal.pone.0055494
Abstract
Numerous clinical trials have demonstrated that elderly patients with colorectal cancer (CRC) can benefit from chemotherapy, yet compliance in real-world practice is low. The purpose of this study is to investigate the efficacy, compliance and reasons for refusal of postoperative chemotherapy for elderly patients with CRC and to provide corresponding strategies. The clinico-pathological and biochemical data of the chemotherapy group and chemo-refusing group were compared among 386 elderly patients (>70 years old) with CRC who underwent surgery. 226 patients received chemotherapy and 160 patients refused. Follow-up of the subjective reasons for refusal was investigated using the elderly caner patients' chemo-refusal reason questionnaire (ECPCRRQ) prepared by the authors and a group of psychologists. The questionnaire is administrated by telephone. A predictive model for 5-year disease-free survival (DFS) and 5-year overall survival (OS) was constructed by using Kaplan-Meier analysis, logistic and Cox regression. Among stage III patients, receiving chemotherapy was associated with a significantly higher OS (68%) compared to those who refused (OS50%) (HR: 2.05, 95%CI: 1.12–3.77, P = 0.02). The Chemo-refusal group had more female and elderly patients, significantly higher rate of severe complications, and lower body mass index (BMI). Follow-up phone questionnaire analysis showed the doctors’ uncertainty of chemotherapy benefit, economic difficulties, uncomfortable feeling, superstition of Traditional Chinese Medicine, concealing information and lack of social support were the main factors for elderly CRC patients to decline chemotherapy. The receipt of post-operative chemotherapy in elderly patients with resected stage III CRC was associated with a more favorable survival. The low compliance rate (160/386) of postoperative chemotherapy was influenced by various subjective and objective factors.Keywords
This publication has 35 references indexed in Scilit:
- Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, CanadaCancer, 2011
- German cancer statistics 2004BMC Cancer, 2010
- The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literatureRadiotherapy and Oncology, 2008
- The role of traditional Chinese medicine in colorectal cancer treatmentTechniques in Coloproctology, 2008
- Benefits and risks of palliative capecitabine based therapy to elderly patients with advanced colorectal cancer: Danish single centre experiencesActa Oncologica, 2006
- Trends in the management and survival of digestive tract cancers among patients aged over 80 yearsAlimentary Pharmacology & Therapeutics, 2005
- Treatment of stage IV colorectal carcinoma in elderly patientsCritical Reviews in Oncology/Hematology, 2005
- Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trialsAnnals Of Oncology, 2004
- Age, Sex, and Racial Differences in the Use of Standard Adjuvant Therapy for Colorectal CancerJournal of Clinical Oncology, 2002
- A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly PatientsNew England Journal of Medicine, 2001